Evidence map›Paper›PMID 37143670›Full record

ArticleFrontiers in immunology2023

Complete variable domain sequences of monoclonal antibody light chains identified from untargeted RNA sequencing data.

Allison Nau, Yun Shen, Vaishali Sanchorawala, Tatiana Prokaeva, Gareth J Morgan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Allison NauAmyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Yun ShenResearch Computing Services, Boston University, Boston, MA, United States.
Vaishali SanchorawalaAmyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Tatiana ProkaevaAmyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Gareth J MorganAmyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Amyloidosis Foundation · USBoston University · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
NCATS NIH HHS UL1 TR001430
6 · The paper itself

Abstract

Introduction: Monoclonal antibody light chain proteins secreted by clonal plasma cells cause tissue damage due to amyloid deposition and other mechanisms. The unique protein sequence associated with each case contributes to the diversity of clinical features observed in patients. Extensive work has characterized many light chains associated with multiple myeloma, light chain amyloidosis and other disorders, which we have collected in the publicly accessible database, AL-Base. However, light chain sequence diversity makes it difficult to determine the contribution of specific amino acid changes to pathology. Sequences of light chains associated with multiple myeloma provide a useful comparison to study mechanisms of light chain aggregation, but relatively few monoclonal sequences have been determined. Therefore, we sought to identify complete light chain sequences from existing high throughput sequencing data. Methods: We developed a computational approach using the MiXCR suite of tools to extract complete rearranged Results: Monoclonal Discussion: Our method allows routine identification of clonal antibody sequences from RNA sequencing data collected for gene expression studies. The sequences identified represent, to our knowledge, the largest collection of multiple myeloma-associated light chains reported to date. This work substantially increases the number of monoclonal light chains known to be associated with non-amyloid plasma cell disorders and will facilitate studies of light chain pathology.

Indexed as

Multiple MyelomaAntibodies, MonoclonalHumansImmunoglobulin Light ChainsRNASequence Analysis, RNAAntibodies, MonoclonalImmunoglobulin Light ChainsRNAAL amyloidosisantibody light chainantibody repertoire sequencingantibody sequenceMiXCRmonoclonal gammopathymultiple myelomaplasma cell dyscrasia

Identifiers

PMID37143670
PMCPMC10151772
OpenAlexW4366290700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.